<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-32793" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Wells Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Toumi</surname>
            <given-names>Asma</given-names>
          </name>
          <aff>Charles Nicolle Hosp of Tunis Un Tunis</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yarrarapu</surname>
            <given-names>Siva Naga S.</given-names>
          </name>
          <aff>Monmouth Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Litaiem</surname>
            <given-names>Noureddine</given-names>
          </name>
          <aff>University of Tunis El Manar</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Asma Toumi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Siva Naga Yarrarapu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Noureddine Litaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-32793.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Wells syndrome is characterized by sudden onset of large, inflamed, edematous patches that are often covered with vesicles or bullae; typically, the eruption is preceded by sensations of itching or burning. The lesions may or may not be associated with a low fever, and lesions are preferentially located on the trunk and the extremities. In the days following the initial eruption, the lesions evolve, demonstrating an extension of the patches, which take an annular configuration, with the center healing while the border becomes purple. Inflammatory signs regress within about 10 days while the plaques become indurated and patients typically recover completely and skin appears normal within 4 to 6 weeks. Recurrence is the rule, with variable locations, and the period between recurrences varies from months to several years; however, the prognosis remains good with long-term recovery. This activity reviews the evaluation of Wells syndrome and addresses the role of the interprofessional team in managing this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the pathophysiology of Wells syndrome.</p></list-item><list-item><p>Describe the presentation of Wells syndrome.</p></list-item><list-item><p>Summarize the treatment of Wells syndrome.</p></list-item><list-item><p>Articulate the role of an interprofessional team in evaluating and improving care for patients with Wells syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=32793&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=32793">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-32793.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Described in 1971, Wells syndrome is a rare dermatosis&#x000a0;of unknown etiology. It is characterized by a benign but recurrent evolution. Wells syndrome is mainly observed in adults but can occur at any age.<xref ref-type="bibr" rid="article-32793.r1">[1]</xref><xref ref-type="bibr" rid="article-32793.r2">[2]</xref><xref ref-type="bibr" rid="article-32793.r3">[3]</xref>&#x000a0;Family cases have been described, but in most cases, this cutaneous disorder is sporadic.</p>
      </sec>
      <sec id="article-32793.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The pathogenesis of Wells syndrome is unknown. It may be explained as an inappropriate eosinophilic reaction to a wide variety of stimuli due to an abnormal function of eosinophil regulatory systems. Many triggering factors have been proposed: insect bites, drugs, allergic contact dermatitis, an underlying myeloproliferative disorder, and infections (e.g., dermatophytes, viruses, Toxocara canis).</p>
      </sec>
      <sec id="article-32793.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Wells syndrome is a rare dermatosis with fewer&#x000a0;than&#x000a0;200 cases published in the literature.&#x000a0;It is mainly observed in adults but also in children.<xref ref-type="bibr" rid="article-32793.r1">[1]</xref><xref ref-type="bibr" rid="article-32793.r3">[3]</xref></p>
      </sec>
      <sec id="article-32793.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenesis of Wells syndrome is obscure. Many triggering factors&#x000a0;have been reported including insect bites,&#x000a0;viral infections (parvovirus B19, herpes simplex virus, varicella-zoster virus, mumps virus),&#x000a0;parasitic infections<xref ref-type="bibr" rid="article-32793.r4">[4]</xref>&#x000a0;(Ascaris, Toxocara canis, Giardia), bacterial or fungal infections, drugs (antibiotics, non-steroidal anti-inflammatory drugs, thiazide diuretics, anti-TNF, biomedicines) and vaccines. Association of Wells syndrome with other diseases has also been described such as hematologic malignancies (chronic myeloid leukemia,<xref ref-type="bibr" rid="article-32793.r5">[5]</xref>&#x000a0;chronic lymphocytic leukemia, polycythemia vera, non-Hodgkin lymphoma), malignant tumors, ulcerative colitis,<xref ref-type="bibr" rid="article-32793.r6">[6]</xref>&#x000a0;eosinophilic granulomatosis with polyangiitis (Churg&#x02013;Strauss syndrome),<xref ref-type="bibr" rid="article-32793.r7">[7]</xref>&#x000a0;hypereosinophilic syndrome<xref ref-type="bibr" rid="article-32793.r8">[8]</xref>). Wells syndrome may be prior, revealing, or concomitant to these diseases. The fortuitous nature of some of these situations cannot be ruled out, but one must remain vigilant in case of prolonged evolution beyond 6 months, persistent eosinophilia, and/or systemic manifestations associated with Wells syndrome.<xref ref-type="bibr" rid="article-32793.r9">[9]</xref></p>
        <p>The most interesting associations from a pathogenic point of view are certainly&#x000a0;those belonging to the spectrum of eosinophilic diseases,<xref ref-type="bibr" rid="article-32793.r10">[10]</xref>&#x000a0;such as Shulman syndrome, Churg-Strauss syndrome, and hypereosinophilic syndrome. Wells syndrome could be the first clinical manifestation of these diseases.<xref ref-type="bibr" rid="article-32793.r7">[7]</xref><xref ref-type="bibr" rid="article-32793.r8">[8]</xref><xref ref-type="bibr" rid="article-32793.r11">[11]</xref></p>
        <p>The physiopathogenic links between the triggering factors and the associations mentioned above are not clearly established. Inappropriate activation of a Th2-like T lymphocyte clone, synthesizing IL-5, and other eosinophil-stimulating cytokines in response to various, often unidentified, antigenic stimuli is the commonly accepted assumption.</p>
      </sec>
      <sec id="article-32793.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histological images vary according to the progressive stage of the lesions.&#x000a0;Initially, significant edema and a dermal infiltrate of eosinophils&#x000a0;are&#x000a0;seen. Some of the eosinophils are degranulated.&#x000a0;The sub-acute stage is characterized by images called &#x0201c;flame-figures,&#x0201d; located&#x000a0;in the mid to deep dermis. The flame-figures are composed of a central part consisting of collagen fibers and eosinophilic granules, surrounded by a histiocytic and eosinophilic infiltrate.<xref ref-type="bibr" rid="article-32793.r12">[12]</xref>&#x000a0;Subsequently, eosinophils tend to&#x000a0;disappear and are replaced by phagocytic granulomas, consisting of histiocytes and sometimes giant cells, around the flame figures. The absence of vasculitis is an important negative sign.</p>
        <p>The flame-figures are not specific to Wells syndrome and can be observed in many other skin conditions in which degranulation of eosinophils occurs including prurigo, eczema, arthropod bite, scabies, bullous pemphigoid, pemphigus&#x000a0;vegetans, and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).</p>
        <p>The study in electron microscopy shows many eosinophils in degranulation, expressing signs of membrane cytolysis. Intact or fragmented free granules are seen in the dermis around the collagen fibers, thus forming the flame figures.<xref ref-type="bibr" rid="article-32793.r13">[13]</xref></p>
        <p>The diversity of clinical aspects of Wells syndrome is probably explained by the level of eosinophilic infiltrate, which may be dermic (superficial or deep), hypodermic thus giving an image of eosinophilic panniculitis,<xref ref-type="bibr" rid="article-32793.r14">[14]</xref>&#x000a0;or even subcutaneous.<xref ref-type="bibr" rid="article-32793.r15">[15]</xref></p>
      </sec>
      <sec id="article-32793.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Wells described the first patient in 1971 as &#x0201c;recurrent granulomatous dermatitis with eosinophilia.&#x0201d; He later renamed the disease &#x0201c;eosinophilic cellulitis.&#x0201d;<xref ref-type="bibr" rid="article-32793.r1">[1]</xref>&#x000a0;In 1979,&#x000a0;Spiegel&#x000a0;and Winkelmann proposed the eponym "Wells syndrome."</p>
        <p>Wells syndrome has a sudden onset. In the classic form, symptomatology is marked by large well limited inflammatory erythematous and edematous patches that are often covered with vesicles or bullae. The lesions are located preferentially on the trunk and the extremities.&#x000a0;The eruption is preceded by sensations of itching or burning.&#x000a0;General signs are rare. A low fever can be associated&#x000a0;with cutaneous symptoms. The evolution in the following days is marked by an extension of the patches, which take an annular configuration, with the center healing while the border becomes purple. Inflammatory signs regress within approximately 10 days while the plaques become indurated. Restitutio ad&#x000a0;integrum&#x000a0;usually occurs in 4 to 6 weeks. Recurrence is the rule, with variable locations. The period between recurrences varies from a few months to several years; however, the prognosis remains good with long-term recovery.</p>
      </sec>
      <sec id="article-32793.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Biologically, the main element is peripheral blood eosinophilia which is&#x000a0;found in about 50% of cases during the acute phase.</p>
      </sec>
      <sec id="article-32793.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of Wells syndrome is not codified. Apart from the etiological treatment of a triggering or associated disease, corticosteroids and dapsone are the two main treatments for Wells syndrome.</p>
        <p>
<bold>Therapeutic Agents</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes"><bold>Corticosteroids:</bold></italic> It is the reference treatment for all&#x000a0;reactional dermatoses whether neutrophilic or eosinophilic. General corticotherapy reduces the duration and importance of relapses in 10% of cases.<xref ref-type="bibr" rid="article-32793.r2">[2]</xref>&#x000a0;Initial doses range from 0.5 to 1 mg/kg/day, with rapid tapering. During the decrease of the treatment, it is not uncommon to observe a relapse of the lesions, which can lead, in certain cases, to a real corticosteroid dependence. Local corticosteroids represent an interesting alternative to general corticosteroids, especially in superficial forms, with inconsistent results of the order of 50%.<xref ref-type="bibr" rid="article-32793.r2">[2]</xref>&#x000a0;However, it should not be used in deep hypodermic or extended forms.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"><bold>Dapsone:</bold></italic> Dapsone is an interesting therapeutic alternative to corticosteroids, with doses ranging from 50 to 200 mg daily. It would reduce the duration of relapses. The optimal duration of treatment is not clearly defined but can be several months in the absence of adverse effects requiring discontinuation of treatment. It can be used alone or in combination with other treatments, including corticosteroids. It can also serve as a relay for general corticosteroids, especially in cases of corticosteroid dependence.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"><bold>Antihistamines:</bold></italic> Antihistamines, especially hydroxyzine if pruritus, is important and&#x000a0;maybe tried&#x000a0;as a first intention, because of their excellent tolerance even if their effectiveness does not seem to exceed 25% of the cases.<xref ref-type="bibr" rid="article-32793.r2">[2]</xref>&#x000a0;They sometimes allow the practitioner to avoid&#x000a0;the use of general steroid treatment. The dosage varies from 50 to 100 mg/day. Hydroxyzine can be combined with other antihistamines.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"><bold>Other treatments:</bold></italic>&#x000a0;These are all anecdotal, with their interest being reported in only a few clinical cases.<xref ref-type="bibr" rid="article-32793.r16">[16]</xref>&#x000a0;Colchicine, PUVA (psoralen and ultraviolet A) therapy, interferon-alpha, cyclins <xref ref-type="bibr" rid="article-32793.r17">[17]</xref>, synthetic antimalarials, ciclosporin,&#x000a0;and anti-TNF agents can be mentioned.<xref ref-type="bibr" rid="article-32793.r18">[18]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Therapeutic Strategy</bold>
</p>
        <p>In most cases, general corticosteroids (10 to 80 mg daily) allow rapid healing. Tapering the dose over one month is generally well tolerated. Continued low-dose therapy with corticosteroids allows preventing recurrences. Dapsone may be prescribed as first-line treatment in low inflammatory forms. It also seems to give good results in case of&#x000a0;corticosteroids resistance <xref ref-type="bibr" rid="article-32793.r13">[13]</xref>.&#x000a0;IFN-alpha and IFN-beta could represent interesting alternatives.<xref ref-type="bibr" rid="article-32793.r19">[19]</xref><xref ref-type="bibr" rid="article-32793.r20">[20]</xref>&#x000a0;For mild cases, topical corticosteroids may be sufficient. Finally, the treatment of an associated disease, when it is found, is essential. It&#x000a0;must&#x000a0;be prescribed as a first-line treatment and can cure Wells syndrome.<xref ref-type="bibr" rid="article-32793.r21">[21]</xref></p>
      </sec>
      <sec id="article-32793.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Acute bacterial cellulitis is eliminated in front of the absence of infectious context (fever, leukocytosis) and recurrent evolution. The histopathologic findings of bacteria cellulitis can also include significant edema, but neutrophils are the predominant inflammatory cell in these infections. In rare cases, clinical and histological similarities have been described with chronic erythema migratory. Eosinophilic annular erythema is also a differential diagnosis, but this entity is considered by many to be a subset of Wells syndrome.</p>
      </sec>
      <sec id="article-32793.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Wells syndrome can be easily mistaken for acute bacterial cellulitis; therefore, first-line practitioners should be well aware of this&#x000a0;dermatosis.</p>
        <p>Moreover, Wells syndrome can be associated with&#x000a0;other diseases&#x000a0;such as hematologic malignancies (chronic myeloid leukemia,<xref ref-type="bibr" rid="article-32793.r5">[5]</xref>&#x000a0;chronic lymphocytic leukemia, polycythemia vera, non-Hodgkin lymphoma), malignant tumors, ulcerative colitis,<xref ref-type="bibr" rid="article-32793.r6">[6]</xref>&#x000a0;eosinophilic granulomatosis with polyangiitis (Churg&#x02013;Strauss syndrome),<xref ref-type="bibr" rid="article-32793.r7">[7]</xref>&#x000a0;hypereosinophilic syndrome,<xref ref-type="bibr" rid="article-32793.r8">[8]</xref>&#x000a0;which implies cooperation&#x000a0;with dermatologists, hematologists, oncologists, and internists&#x000a0;to improve patient-centered care.</p>
        <p>Furthermore, the diagnosis of Wells syndrome is mainly based on the histological study and the identification of flame-figures, but these findings are not specific to Wells syndrome and can be observed in many other skin conditions such as prurigo, eczema, arthropod bite, scabies, bullous pemphigoid, pemphigus&#x000a0;vegetans, and eosinophilic granulomatosis with polyangiitis. Therefore, clinicopathologic&#x000a0;conferences are highly recommended&#x000a0;to establish the correct diagnosis.</p>
      </sec>
      <sec id="article-32793.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=32793&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=32793">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/wells-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=32793">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/32793/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=32793">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-32793.s13">
        <title>References</title>
        <ref id="article-32793.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wells</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>NP</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic cellulitis.</article-title>
            <source>Br J Dermatol</source>
            <year>1979</year>
            <month>Jan</month>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-9</page-range>
            <pub-id pub-id-type="pmid">427009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lacroix</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Izadpanah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borsuk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Watters</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gilardino</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of eosinophilic cellulitis (Wells' syndrome): A case series and literature review.</article-title>
            <source>Can J Plast Surg</source>
            <year>2012</year>
            <season>Summer</season>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>91</fpage>
            <page-range>91-7</page-range>
            <pub-id pub-id-type="pmid">23730155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caputo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marzano</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Vezzoli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lunardon</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Wells syndrome in adults and children: a report of 19 cases.</article-title>
            <source>Arch Dermatol</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>142</volume>
            <issue>9</issue>
            <fpage>1157</fpage>
            <page-range>1157-61</page-range>
            <pub-id pub-id-type="pmid">16983003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Canonne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dubost-Brama</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Segard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piette</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Delaporte</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Wells' syndrome associated with recurrent giardiasis.</article-title>
            <source>Br J Dermatol</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>143</volume>
            <issue>2</issue>
            <fpage>425</fpage>
            <page-range>425-7</page-range>
            <pub-id pub-id-type="pmid">10951158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakazato</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hamade</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nemoto-Hasebe</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sugita</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nishie</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Wells' syndrome associated with chronic myeloid leukaemia.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2013</year>
            <month>May</month>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>375</fpage>
            <page-range>375-6</page-range>
            <pub-id pub-id-type="pmid">23147913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Utikal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peitsch</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Kemmler</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Booken</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hildenbrand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gladisch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Goerdt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goebeler</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bullous eosinophilic cellulitis associated with ulcerative colitis: effective treatment with sulfasalazine and glucocorticoids.</article-title>
            <source>Br J Dermatol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>156</volume>
            <issue>4</issue>
            <fpage>764</fpage>
            <page-range>764-6</page-range>
            <pub-id pub-id-type="pmid">17263808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ratzinger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zankl</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zelger</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Wells syndrome and its relationship to Churg-Strauss syndrome.</article-title>
            <source>Int J Dermatol</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>52</volume>
            <issue>8</issue>
            <fpage>949</fpage>
            <page-range>949-54</page-range>
            <pub-id pub-id-type="pmid">23786445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujii</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanabe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kanno</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Konishi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ohgou</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic cellulitis as a cutaneous manifestation of idiopathic hypereosinophilic syndrome.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>1174</fpage>
            <page-range>1174-7</page-range>
            <pub-id pub-id-type="pmid">14639412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Salim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muc</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Colloby</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Persistent hypereosinophilia with Wells syndrome.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-3</page-range>
            <pub-id pub-id-type="pmid">22607377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delaporte</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>[From Wells syndrome to "eosinophilic disease"].</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>128</volume>
            <issue>3 Pt 1</issue>
            <fpage>207</fpage>
            <page-range>207-11</page-range>
            <pub-id pub-id-type="pmid">11319381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>French</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Junkins-Hopkins</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wolfe</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Rook</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>1170</fpage>
            <page-range>1170-4</page-range>
            <pub-id pub-id-type="pmid">14639411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brehmer-Andersson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kaaman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Skog</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Frithz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The histopathogenesis of the flame figure in Wells' syndrome based on five cases.</article-title>
            <source>Acta Derm Venereol</source>
            <year>1986</year>
            <volume>66</volume>
            <issue>3</issue>
            <fpage>213</fpage>
            <page-range>213-9</page-range>
            <pub-id pub-id-type="pmid">2426897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aberer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Konrad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Wells' syndrome is a distinctive disease entity and not a histologic diagnosis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1988</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1 Pt 1</issue>
            <fpage>105</fpage>
            <page-range>105-14</page-range>
            <pub-id pub-id-type="pmid">3279079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Consigny</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Courville</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gauthier</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Maillard</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Detienne</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lauret</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Histological and clinical forms of the eosinophilic cellulitis].</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>128</volume>
            <issue>3 Pt 1</issue>
            <fpage>213</fpage>
            <page-range>213-6</page-range>
            <pub-id pub-id-type="pmid">11319382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zloczower</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zur Nedden</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Helweg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fritsch</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Eosinophilic cellulitis (Wells syndrome) with involvement of para-articular muscles and fascia].</article-title>
            <source>Hautarzt</source>
            <year>1994</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>8</issue>
            <fpage>551</fpage>
            <page-range>551-3</page-range>
            <pub-id pub-id-type="pmid">7960756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Cusack</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Wells syndrome: an enigmatic and therapeutically challenging disease.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>9</issue>
            <fpage>908</fpage>
            <page-range>908-11</page-range>
            <pub-id pub-id-type="pmid">17039661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stam-Westerveld</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Daenen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Van der Meer</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Jonkman</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic cellulitis (Wells' syndrome): treatment with minocycline.</article-title>
            <source>Acta Derm Venereol</source>
            <year>1998</year>
            <month>Mar</month>
            <volume>78</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <pub-id pub-id-type="pmid">9534905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarin</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Fiorentino</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Treatment of recalcitrant eosinophilic cellulitis with adalimumab.</article-title>
            <source>Arch Dermatol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>148</volume>
            <issue>9</issue>
            <fpage>990</fpage>
            <page-range>990-2</page-range>
            <pub-id pub-id-type="pmid">22986848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Husak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Goerdt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Orfanos</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Interferon alfa treatment of a patient with eosinophilic cellulitis and HIV infection.</article-title>
            <source>N Engl J Med</source>
            <year>1997</year>
            <month>Aug</month>
            <day>28</day>
            <volume>337</volume>
            <issue>9</issue>
            <fpage>641</fpage>
            <page-range>641-2</page-range>
            <pub-id pub-id-type="pmid">9280840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yagi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tokura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsushita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hanaoka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Takigawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Wells' syndrome: a pathogenic role for circulating CD4+CD7- T cells expressing interleukin-5 mRNA.</article-title>
            <source>Br J Dermatol</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>136</volume>
            <issue>6</issue>
            <fpage>918</fpage>
            <page-range>918-23</page-range>
            <pub-id pub-id-type="pmid">9217826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32793.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YM</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic cellulitis in a patient with gastric cancer.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>89</volume>
            <issue>6</issue>
            <fpage>644</fpage>
            <page-range>644-5</page-range>
            <pub-id pub-id-type="pmid">19997702</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
